Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endometrial Carcinomas With Subclonal Loss of Mismatch Repair Proteins

3 Mar 2023

Abstract excerpt

Subclonal loss of mismatch repair (MMR) proteins has been described in a small subset of endometrial carcinomas (ECs), but the genomic basis for this phenomenon has received limited attention. Herein, we retrospectively evaluated all ECs with MMR immunohistochemistry (n=285) for subclonal loss, and in those (n=6), performed a detailed clinicopathologic and genomic comparison of the MMR-deficient and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial and Cervical Cancer Treatments
Share to Genetic factors in colorectal cancer
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36866757
DOI: 10.1097/pas.0000000000002031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endometrial Carcinomas With Subclonal Loss of Mismatch Repair ProteinsPMID 36866757Read ↗

Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial CarcinomaSemantic proximity Read ↗

DNA Mismatch Repair–deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional CarcinosarcomasSemantic proximity Read ↗

Characterization of mismatch‐repair/microsatellite instability‐discordant endometrial cancersSemantic proximity Read ↗

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudySemantic proximity Read ↗

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical ImplicationsSemantic proximity Read ↗

Mutation profile and molecular heterogeneity in mismatch repair deficient endometrial carcinomaSemantic proximity Read ↗

Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancerSemantic proximity Read ↗

Abrupt Loss of MLH1 and PMS2 Expression in Endometrial CarcinomaSemantic proximity Read ↗

Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter HypermethylationSemantic proximity Read ↗

Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability.Semantic proximity Read ↗

A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancerSemantic proximity Read ↗

Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.